Serological Typing of Branhamella Catarrhalis Strains on the Basis of Lipopolysaccharide Antigens

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1990 Feb 1

PMID 2107197

Citations 40

Authors

M Vaneechoutte

G Verschraegen

G Claeys

A M Van den Abeele

Affiliations

Soon will be listed here.

Abstract

A total of 302 strains of Branhamella catarrhalis from different parts of the world were serologically typed according to their lipopolysaccharide (LPS) antigenicity. For this purpose, an inhibition enzyme-linked immunosorbent assay was developed using the following reagents: antisera raised against whole bacterial suspensions for a panel of 16 serotype strains and LPS prepared from these strains by phenol extraction. Antisera were absorbed with whole bacterial suspensions of the B. catarrhalis strains to be tested. The residual activity of the sera against the homologous LPS was determined by means of an enzyme-linked immunosorbent assay, using microdilution plates coated with LPS. Strains which gave greater than 90% reduction of activity were considered to carry the same LPS type as the serotype strain. It was shown that 93.4% of the strains tested carried one of three possible LPS types. LPS of B. catarrhalis are the rough type and have an apparent Mr of 5,500, as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Citing Articles

The characterization of carried in the general population.

Morris D, Osman K, Cleary D, Clarke S Microb Genom. 2022; 8(5).

PMID: 35639578 PMC: 9465073. DOI: 10.1099/mgen.0.000820.

Potential targets for next generation antimicrobial glycoconjugate vaccines.

Micoli F, Costantino P, Adamo R FEMS Microbiol Rev. 2018; 42(3):388-423.

PMID: 29547971 PMC: 5995208. DOI: 10.1093/femsre/fuy011.

Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.

Earl J, de Vries S, Ahmed A, Powell E, Schultz M, Hermans P Genome Biol Evol. 2016; 8(4):955-74.

PMID: 26912404 PMC: 4860680. DOI: 10.1093/gbe/evw039.

Vaccine targets against Moraxella catarrhalis.

Ren D, E Pichichero M Expert Opin Ther Targets. 2015; 20(1):19-33.

PMID: 26565427 PMC: 4720561. DOI: 10.1517/14728222.2015.1081686.

An Unusual Carbohydrate Conformation is Evident in Moraxella catarrhalis Oligosaccharides.

Frank M, Collins P, Peak I, Grice I, Wilson J Molecules. 2015; 20(8):14234-53.

PMID: 26251889 PMC: 6332130. DOI: 10.3390/molecules200814234.

References

COFFEY Jr J . Otitis media in the practice of pediatrics. Bacteriological and clinical observations. Pediatrics. 1966; 38(1):25-32. View

Patterson J, Patterson T, Farrel P, Hierholzer Jr W, Zervos M . Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol. 1989; 27(5):944-6. PMC: 267459. DOI: 10.1128/jcm.27.5.944-946.1989. View

Lambert M, Hollis D, MOSS C, Weaver R, Thomas M . Cellular fatty acids of nonpathogenic Neisseria. Can J Microbiol. 1971; 17(12):1491-502. DOI: 10.1139/m71-239. View

Frasch C, CHAPMAN S . Classification of Neisseria meningitidis group B into distinct serotypes. IV. Preliminary chemical studies on the nature of the serotype antigen. Infect Immun. 1972; 6(5):674-81. PMC: 422592. DOI: 10.1128/iai.6.5.674-681.1972. View

Voller A, Draper C, BIDWELL D, Bartlett A . Microplate enzyme-linked immunosorbent assay for chagas' disease. Lancet. 1975; 1(7904):426-8. DOI: 10.1016/s0140-6736(75)91492-0. View

Johnson K, McDonald I, Perry M . Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis. Can J Microbiol. 1976; 22(4):460-7. DOI: 10.1139/m76-072. View

Frasch C, McNelis R, Gotschlich E . Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J Bacteriol. 1976; 127(2):973-81. PMC: 233007. DOI: 10.1128/jb.127.2.973-981.1976. View

Brorson J, Axelsson A, Holm S . Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976; 8(3):151-5. DOI: 10.3109/inf.1976.8.issue-3.05. View

Zollinger W, Mandrell R . Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infect Immun. 1977; 18(2):424-33. PMC: 421250. DOI: 10.1128/iai.18.2.424-433.1977. View

10.

Apicella M, GAGLIARDI N . Antigenic heterogeneity of the non-serogroup antigen structure of Neisseria gonorrhoeae lipopolysaccharides. Infect Immun. 1979; 26(3):870-4. PMC: 414700. DOI: 10.1128/iai.26.3.870-874.1979. View

11.

Schalen L, Christensen P, Kamme C, Miorner H, Pettersson K, Schalen C . High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis. 1980; 12(4):277-80. DOI: 10.3109/inf.1980.12.issue-4.07. View

12.

BRZIN B . Branhamella catarrhalis as a human pathogen and a possible hospital infectant. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1981; 249(4):483-6. View

13.

Tsai C, Frasch C . A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982; 119(1):115-9. DOI: 10.1016/0003-2697(82)90673-x. View

14.

Tsai C, Boykins R, Frasch C . Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides. J Bacteriol. 1983; 155(2):498-504. PMC: 217716. DOI: 10.1128/jb.155.2.498-504.1983. View

15.

Mintz C, Apicella M, Morse S . Electrophoretic and serological characterization of the lipopolysaccharide produced by Neisseria gonorrhoeae. J Infect Dis. 1984; 149(4):544-52. DOI: 10.1093/infdis/149.4.544. View

16.

Schneider H, Hale T, Zollinger W, Seid Jr R, Hammack C, Griffiss J . Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun. 1984; 45(3):544-9. PMC: 263327. DOI: 10.1128/iai.45.3.544-549.1984. View

17.

Ahmad F, McLeod D, Power J, CALDER M . Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect. 1985; 6(1):71-4. DOI: 10.1016/s0195-6701(85)80020-7. View

18.

Davies B, MAESEN F . Branhamella catarrhalis chest infections. Lancet. 1986; 2(8501):278. DOI: 10.1016/s0140-6736(86)92088-x. View

19.

Mandrell R, Schneider H, Apicella M, Zollinger W, Rice P, Griffiss J . Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect Immun. 1986; 54(1):63-9. PMC: 260117. DOI: 10.1128/iai.54.1.63-69.1986. View

20.

Van Hare G, Shurin P, Marchant C, Cartelli N, Johnson C, Fulton D . Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987; 9(1):16-27. DOI: 10.1093/clinids/9.1.16. View